Reckitt Benckiser in talks to acquire Mead Johnson for US$16.7b
New York
RECKITT Benckiser Group Plc is in talks to buy baby formula maker Mead Johnson Nutrition Co for about US$16.7 billion, the latest push by the Durex condom maker to build on its faster growing consumer-health business and bolster its presence in Asian markets.
The companies are discussing an offer of US$90 a share in cash, Reckitt Benckiser said late on Wednesday. That's 29 per cent higher than Mead Johnson's closing stock price. Reckitt Benckiser, based in Slough, England, would finance its biggest-ever deal with cash and debt. Mead Johnson confirmed the discussions in a separate statement, and both companies said there is no certainty that any transaction will ultimately be agreed on.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
HSBC CEO to retire; bank reports 1.7% lower Q1 profit of US$10.8 billion
Huawei profit surges 564% as it eclipses Apple in China
Singapore stocks rise, tracking regional bourses; STI up 0.3%
Boosted by name brand beers, Carlsberg sees higher sales
JPMorgan promotes about 150 in Asia, EMEA to managing director
Brokers’ take: Analysts upgrade iFast’s rating on higher growth expectations